Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients Meeting Abstract

  

Authors:	Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; Ragupathi, G.; Lyashchenko, S. K.; William, S. P.; Larson, S. M.; Scher, H. I.; Fine, B. M.; Morris, M. J.
Abstract Title:	Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
Meeting Title:	105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	74
Issue:	19 Suppl.
Meeting Dates:	2014 Apr 5-9
Meeting Location:	San Diego, CA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2014-10-01
Language:	English
ACCESSION:	WOS:000349906902281
DOI:	10.1158/1538-7445.am2014-2069
PROVIDER:	wos
Notes:	Meeting Abstract: 2069 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/74681